| A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma (NCT02659020) | Eli Lilly and Company | 2016-03-01 |
| Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I (NCT02709954) | Yale University | 2016-03-01 |
| Intrauterine Autologous PRP Infusion Compared to HRT for Enhancing Endometrial Thickness in Patients Undergoing ICSI (NCT02660294) | Ain Shams University | 2016-03-01 |
| A Study of PLX51107 in Advanced Malignancies (NCT02683395) | Plexxikon | 2016-03-01 |
| the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL) (NCT02737085) | Southwest Hospital, China | 2016-03-01 |
| Cultivated Autologous Oral Mucosal Epithelial Transplantation (NCT03943797) | Chang Gung Memorial Hospital | 2016-03-01 |
| Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer (NCT02737228) | CrystalGenomics, Inc. | 2016-03-01 |
| PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy (NCT02644694) | Eyegate Pharmaceuticals, Inc. | 2016-03-01 |
| Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea (NCT02680717) | Medical College of Wisconsin | 2016-03-01 |
| Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) (NCT02676310) | Allergan | 2016-03-01 |
| Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients (NCT02946671) | Osaka University | 2016-03-01 |
| A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. Malignancies (NCT02730481) | Athenex, Inc. | 2016-03-01 |
| Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection (NCT02707900) | University of North Carolina, Chapel Hill | 2016-03-01 |
| A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects (NCT02817932) | A.Menarini Asia-Pacific Holdings Pte Ltd | 2016-03-01 |
| A Study of RC48-ADC in Subjects With HER2-Positive Advanced Malignant Solid Tumors (NCT02881138) | RemeGen Co., Ltd. | 2016-03-01 |
| The Capillary Index Score Trial (NCT02618031) | Firas Al-Ali | 2016-03-01 |
| The Cellular Pharmacology of F-TAF in Dried Blood Spots (NCT02962739) | University of Colorado, Denver | 2016-03-01 |
| A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer (NCT02713984) | Zhi Yang | 2016-03-01 |
| Misoprostol Prior to Intrauterine Contraceptive Device Insertion (NCT02412033) | Assiut University | 2016-03-01 |
| Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE (NCT02686346) | The Lymphoma Academic Research Organisation | 2016-03-01 |
| Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol (NCT02402439) | Andrew Posselt | 2016-03-01 |
| Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer (NCT02718859) | Fuda Cancer Hospital, Guangzhou | 2016-03-01 |
| IL-2 in Refractory Autoimmune Encephalitis (NCT02714959) | Seoul National University Hospital | 2016-03-01 |
| Bioavailability of Nasal Naloxone and Injected Naloxone Compared (NCT02598856) | Norwegian University of Science and Technology | 2016-03-01 |
| Pilot Study of Bioequivalence of Cudafol(R) and Diprivan(R) Administered as Single Intravenous Doses in Healthy Subjects (NCT02713802) | Cuda Anesthetics, LLC | 2016-03-01 |
| Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma (NCT02987244) | Peking Union Medical College Hospital | 2016-03-01 |
| ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer (NCT02632071) | Columbia University | 2016-03-01 |
| MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers (NCT02707107) | Wockhardt | 2016-03-01 |
| Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma (NCT02833701) | University of Nebraska | 2016-03-01 |
| Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome (NCT02957123) | Russian Academy of Medical Sciences | 2016-03-01 |
| Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis (NCT02652351) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2016-03-01 |
| Single and Repeated Dose Escalation Study of GSK2838232 (NCT02795754) | GlaxoSmithKline | 2016-03-01 |
| Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles (NCT02820454) | University Hospital, Grenoble | 2016-03-01 |
| Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus (NCT02715193) | REMD Biotherapeutics, Inc. | 2016-03-01 |
| Adipose-derived Stem Cells (ADSCs) for Knee Osteoarthritis (NCT02784964) | UnicoCell Biomed CO. LTD | 2016-03-01 |
| Injectable Collagen Scaffold™ Combined With MSCs Transplantation for Brain Injury (NCT02767817) | Chinese Academy of Sciences | 2016-03-01 |
| High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML (NCT03080922) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2016-03-01 |
| Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients (NCT02687204) | University of Utah | 2016-03-01 |
| Effect of Mebo Dressing Versus Standard Care on Managing Donor and Recipient Sites of Split-thickness Skin Graft (NCT02737943) | Zagazig University | 2016-03-01 |
| A Study to Assess the Absorption, Metabolism, and Routes of Excretion Following Oral Administration of (14C) Radiolabeled JNJ--42756493 to Healthy Male Participants (NCT02692677) | Janssen Research & Development, LLC | 2016-03-01 |
| Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old (NCT02867319) | Beijing Chaoyang District Centre for Disease Control and Prevention | 2016-03-01 |
| Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older (NCT02708173) | Beijing Chaoyang District Centre for Disease Control and Prevention | 2016-03-01 |
| Effect of Microbial Exposure on Health, Particularly Immune System (NCT03351543) | University of Helsinki | 2016-03-01 |
| Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) (NCT02669017) | ADC Therapeutics S.A. | 2016-03-01 |
| Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC) (NCT02500901) | Paul Mathew, MD | 2016-03-01 |
| Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone (NCT02729376) | LTN PHARMACEUTICALS, INC. | 2016-03-01 |
| Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers (NCT02940314) | Hanmi Pharmaceutical Company Limited | 2016-03-01 |
| Stem Cells in Umbilical Blood Infusion for CP (NCT03087110) | Murdoch Childrens Research Institute | 2016-03-01 |
| Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and Efficacy (NCT02749331) | Uppsala University | 2016-03-01 |
| A Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adults (NCT02729467) | Janssen Research & Development, LLC | 2016-03-01 |
| Effective Methods of Reducing Lower Back, Neck and Shoulder Pain Among Office Workers (NCT02874950) | Universiti Putra Malaysia | 2016-03-01 |
| A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness (NCT02696512) | International Brain Research Foundation | 2016-03-01 |
| Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis (NCT02818543) | Lycera Corp. | 2016-03-01 |
| Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine (NCT02639351) | GlaxoSmithKline | 2016-03-01 |
| A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases (NCT02941744) | Universitair Ziekenhuis Brussel | 2016-03-01 |
| Use of Dalfampridine in Primary Lateral Sclerosis (NCT02868567) | Hospital for Special Surgery, New York | 2016-03-01 |
| Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome (NCT02738450) | AC Immune SA | 2016-03-01 |
| Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer (NCT02695550) | Centaurus Biopharma Co., Ltd. | 2016-03-01 |
| Rimeporide in Patients With Duchenne Muscular Dystrophy (NCT02710591) | EspeRare Foundation | 2016-03-01 |
| To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment. (NCT02679131) | Acrotech Biopharma Inc. | 2016-03-01 |
| Vitamin D Levels Following Topical Application of Vitamin D Ointment (NCT02676674) | University of Minnesota | 2016-03-01 |
| A Study of GPC3 Redirected Autologous T Cells for Advanced HCC (NCT02715362) | Shanghai GeneChem Co., Ltd. | 2016-03-01 |
| A Phase 1 Safety Study of SANGUINATE™ In Patients With Acute Severe Anemia. (NCT02754999) | Prolong Pharmaceuticals | 2016-03-01 |
| The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation (NCT02737735) | First Affiliated Hospital, Sun Yat-Sen University | 2016-03-01 |
| Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis (NCT02722642) | Regend Therapeutics | 2016-03-01 |
| Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer (NCT02566772) | Taiho Oncology, Inc. | 2016-03-01 |
| Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis (NCT02609022) | CuraVac | 2016-03-01 |
| Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set (NCT02687256) | Stanford University | 2016-03-01 |
| Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID (NCT02186977) | Novosanis NV | 2016-03-01 |
| Lipidome and Microbiome Profile of Acne (NCT02713607) | University of California, Davis | 2016-03-01 |
| A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) (NCT02641002) | Celgene | 2016-03-01 |
| A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH) (NCT02651675) | REGENXBIO Inc. | 2016-03-01 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age (NCT02177734) | GlaxoSmithKline | 2016-03-01 |
| Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer (NCT02598726) | Mayo Clinic | 2016-03-01 |
| Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1) (NCT02750345) | Cycle Pharmaceuticals Ltd. | 2016-03-01 |
| Investigation of Single Rising Doses of BI 685509 (NCT02694354) | Boehringer Ingelheim | 2016-03-01 |
| BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone (NCT02670070) | LG Life Sciences | 2016-03-01 |
| Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma (NCT02345824) | University of Virginia | 2016-03-01 |
| Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 "After Multiple Oral Doses" in Healthy Volunteers (NCT02907294) | Palobiofarma SL | 2016-03-01 |
| Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02565901) | University of Washington | 2016-02-29 |
| First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy (NCT02644278) | EMD Serono Research & Development Institute, Inc. | 2016-02-29 |
| An Open Study Assessing the Safety and Tolerability of U3-1784 (NCT02690350) | Daiichi Sankyo | 2016-02-29 |
| Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis (NCT03059693) | Haus Bioceuticals | 2016-02-29 |
| A Phase I Trial of Anti-GD2 T-cells (1RG-CART) (NCT02761915) | Cancer Research UK | 2016-02-29 |
| A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma (NCT02570308) | Immunocore Ltd | 2016-02-29 |
| Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber (NCT03496103) | The University of Texas Medical Branch, Galveston | 2016-02-29 |
| Ibuprofen 4% (w/v) Pivotal Bioequivalence Study (NCT03496324) | Reckitt Benckiser Healthcare (UK) Limited | 2016-02-29 |
| Pharmacokinetic Study of Nanoencapsulated Gel of Lidocaine, Prilocaine and Combination of Lidocaine and Prilocaine (NCT03441841) | Galeno Desenvolvimento de Pesquisas Clínicas | 2016-02-28 |
| A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD) (NCT02674581) | ViiV Healthcare | 2016-02-26 |
| Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine (NCT02846519) | Janssen Research & Development, LLC | 2016-02-26 |
| Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients (NCT02698735) | University of Southern California | 2016-02-25 |
| A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma (NCT02707666) | University of Chicago | 2016-02-25 |
| Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer (NCT02671890) | Mayo Clinic | 2016-02-25 |
| A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC (NCT02630186) | Clovis Oncology, Inc. | 2016-02-24 |
| A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer (NCT02555644) | Eli Lilly and Company | 2016-02-24 |
| A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 (NCT02693093) | Kangen Pharmaceuticals, Inc | 2016-02-24 |
| A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors (NCT02667873) | Stemline Therapeutics, Inc. | 2016-02-23 |
| Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma (NCT02619253) | Nabil Adra | 2016-02-23 |
| Interaction With HIV Antiretroviral Agents (NCT02556268) | Bayer | 2016-02-23 |
| Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis (NCT02620787) | Hartford Hospital | 2016-02-23 |